Press Releases Mydecine Innovations Group Inc.

Equities

MYCOF

CA62849F2008

Market Closed - OTC Markets Other stock markets 02:13:19 2024-05-31 pm EDT			5-day change	1st Jan Change
0.0061 ^USD	-26.51%		-43.52%	-59.06%

May. 01	Mydecine Innovations Group Inc. announced that it expects to receive CAD 1 million in funding	CI
Feb. 23	Mydecine Innovations Closes Partial Debt Settlement	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Mydecine Provides Bi-Weekly Status Report	06:56pm	AQ
Mydecine Provides Bl-Weekly Status Report	May. 16	AQ
Mydecine Applies for Management Cease Trade Order	May. 02	AQ
Mydecine Receives Management Cease Trade Order	May. 02	AQ
Mydecine Innovations Group Inc. Announces Restructuring Transactions and Annual General and Special Meeting	May. 01	AQ
Mydecine Announces Intention to Refile Certain Financial Statements and Applies for Management Cease Trade Order	Apr. 25	AQ
Mydecine Innovations Group Inc. Announces Share for Debt Settlement	Mar. 20	AQ
Mydecine Innovations Group Receives Two Notice of Allowances from USPTO for its MYCO-005 and MYCO-006 Family of Compounds	Feb. 07	GL
Mydecine Innovations Group Receives Two Notice of Allowances from USPTO for its MYCO-005 and MYCO-006 Family of Compounds	Feb. 07	AQ
Mydecine Innovations Group Announces Director Resignation	Feb. 02	GL
Mydecine Innovations Group Receives Notice of Allowance from USPTO for its MYCO-005 Compound	Dec. 18	GL
Mydecine Announces Update Regarding the Special Access Program	Nov. 28	GL
Mydecine Innovations Group Files Prospectus Supplement, Announces Closing Under Share Subscription Agreements	23-10-31	GL
Mydecine Innovations Group Files Prospectus Supplement, Announces Closing Under Share Subscription Agreements	23-10-31	AQ
Mydecine Provides Q4 2023 Business Update	23-10-26	GL
Mydecine Provides Q4 2023 Business Update	23-10-26	AQ
Mydecine Innovations Group gearing up for human trials after completing Aquis listing	23-10-18	AQ
Mydecine Innovations Group Announces Admission to Trading on the AQSE Growth Market in London, UK	23-10-12	GL
Mydecine Innovations Group Announces Admission to Trading on the AQSE Growth Market in London, UK	23-10-12	AQ
Mydecine Innovations Group Announces Admission to Trading on the AQSE Growth Market in London, UK and First Day of Dealings	23-10-10	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Mydecine Innovations Group Inc.

Equities

MYCOF

CA62849F2008

Press Releases

Filters